Inagaki Yuichiro, Ito Tatsuya, Kato Tomonori, Ono Yoshitaka, Sawa Masashi
Department of Hematology and Oncology, Anjo Kosei Hospital, Japan.
Department of Internal Medicine, Narita Hospital, Japan.
Intern Med. 2018 Feb 1;57(3):423-427. doi: 10.2169/internalmedicine.7890-16. Epub 2017 Nov 1.
Mycobacterium colombiense (M. colombiense) is a member of the Mycobacterium avium complex (MAC). To our knowledge, this is the third case report of an M. colombiense infection. An 80-year-old man, immunocompromised by myelodysplastic syndrome (MDS), developed a skin rash with exfoliation and eruption on his face and scalp. Mycobacteria were detected in pus samples. Broad-range polymerase chain reaction (PCR) revealed the mycobacteria to be M. colombiense. The lesions resolved after daily administration of rifampicin, ethambutol, and clarithromycin. In conclusion, broad-range PCR identified this rare mycobacterium, allowing for the administration of appropriate combination antibiotic therapy.
哥伦比亚分枝杆菌(M. colombiense)是鸟分枝杆菌复合群(MAC)的成员。据我们所知,这是第三例哥伦比亚分枝杆菌感染的病例报告。一名80岁男性,因骨髓增生异常综合征(MDS)导致免疫功能低下,面部和头皮出现伴有脱屑和皮疹的皮肤疹。在脓液样本中检测到分枝杆菌。广谱聚合酶链反应(PCR)显示该分枝杆菌为哥伦比亚分枝杆菌。在每日服用利福平、乙胺丁醇和克拉霉素后,皮损消退。总之,广谱PCR鉴定出了这种罕见的分枝杆菌,从而能够进行适当的联合抗生素治疗。